These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 6246993)
21. Separation of the acetylcholinesterase-deficient red cells in paroxysmal nocturnal hemoglobinuria. Chow FL; Hall SE; Rosse WF; Telen MJ Blood; 1986 Apr; 67(4):893-7. PubMed ID: 3955235 [TBL] [Abstract][Full Text] [Related]
22. [Investigation on apoptosis in paroxysmal nocturnal hemoglobinuria (PNH) granulocytes]. Shichishima T Rinsho Byori; 2001 Oct; 49(10):986-91. PubMed ID: 11769477 [TBL] [Abstract][Full Text] [Related]
23. The use of monoclonal antibodies and flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria. Hall SE; Rosse WF Blood; 1996 Jun; 87(12):5332-40. PubMed ID: 8652849 [TBL] [Abstract][Full Text] [Related]
24. Mechanism of complement-mediated activation of human blood platelets in vitro: comparison of normal and paroxysmal nocturnal hemoglobinuria platelets. Dixon RH; Rosse WF J Clin Invest; 1977 Feb; 59(2):360-8. PubMed ID: 833281 [TBL] [Abstract][Full Text] [Related]
25. Relationship between decay accelerating factor deficiency, diminished acetylcholinesterase activity, and defective terminal complement pathway restriction in paroxysmal nocturnal hemoglobinuria erythrocytes. Medof ME; Gottlieb A; Kinoshita T; Hall S; Silber R; Nussenzweig V; Rosse WF J Clin Invest; 1987 Jul; 80(1):165-74. PubMed ID: 2439544 [TBL] [Abstract][Full Text] [Related]
26. Decay-accelerating factor is present on paroxysmal nocturnal hemoglobinuria erythroid progenitors and lost during erythropoiesis in vitro. Moore JG; Frank MM; Müller-Eberhard HJ; Young NS J Exp Med; 1985 Oct; 162(4):1182-92. PubMed ID: 2413153 [TBL] [Abstract][Full Text] [Related]
27. Characterization of the erythropoietic progenitor cells (BFU-E) in paroxysmal nocturnal haemoglobinuria (PNH). Terasawa T; Shichishima T; Matsuda M; Uchida T; Kariyone S Br J Haematol; 1990 Jul; 75(3):428-32. PubMed ID: 2386774 [TBL] [Abstract][Full Text] [Related]
28. Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. I. The sensitivity of PNH red cells to lysis by complement and specific antibody. Rosse WF; Dacie JV J Clin Invest; 1966 May; 45(5):736-48. PubMed ID: 5935361 [No Abstract] [Full Text] [Related]
30. The erythrocytes in paroxysmal nocturnal haemoglobinuria of intermediate sensitivity to complement lysis. Rosse WF; Hoffman S; Campbell M; Borowitz M; Moore JO; Parker CJ Br J Haematol; 1991 Sep; 79(1):99-107. PubMed ID: 1716964 [TBL] [Abstract][Full Text] [Related]
31. Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. II. The role of complement components in the increased sensitivity of PNH red cells to immune lysis. Rosse WF; Dacie JV J Clin Invest; 1966 May; 45(5):749-57. PubMed ID: 4956901 [No Abstract] [Full Text] [Related]
32. Mechanism of paroxysmal nocturnal hemoglobinuria clonal dominance: possible roles of different apoptosis and CD8+ lymphocytes in the selection of paroxysmal nocturnal hemoglobinuria clones. Kunyaboon R; Wanachiwanawin W; U-Pratya Y; Thedsawad A; Taka O Hematol Oncol Stem Cell Ther; 2012; 5(3):138-45. PubMed ID: 23095789 [TBL] [Abstract][Full Text] [Related]
33. Growth of mixed erythroid-granulocytic colonies in culture derived from bone marrow of patients with paroxysmal nocturnal hemoglobinuria without addition of exogenous stimulator. Issaragrisil S; Piankijagum A; Chinprasertsuk S; Kruatrachue M Exp Hematol; 1986 Oct; 14(9):861-6. PubMed ID: 3758236 [TBL] [Abstract][Full Text] [Related]